Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Cash Flow Reinvestment Rate
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow Reinvestment Rate of 7.86x as of December 2025, reinvesting CN¥176.01 Million (capex CN¥7.07 Million plus investments CN¥-168.93 Million) from operating cash flow of CN¥22.41 Million. Check Shanghai Rendu Biotechnology Co. Ltd. A (688193) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. Explore debt repayment capacity of Shanghai Rendu Biotechnology Co. Ltd. A to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year capital reinvestment analysis for Shanghai Rendu Biotechnology Co. Ltd. A. For live market cap and broader valuation context, see 688193 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.86x | CN¥176.01 Million | CN¥22.41 Million | CN¥7.07 Million | ▼ -40.7% |
| 2024 | 13.25x | CN¥323.10 Million | CN¥24.39 Million | CN¥10.52 Million | ▼ -33.5% |
| 2023 | 19.91x | CN¥342.31 Million | CN¥17.19 Million | CN¥20.39 Million | ▲ +2071.2% |
| 2021 | 0.92x | CN¥49.93 Million | CN¥54.44 Million | CN¥26.48 Million | ▲ +145.3% |
| 2020 | 0.37x | CN¥34.62 Million | CN¥92.61 Million | CN¥15.55 Million | ▼ -92.0% |
| 2019 | 4.66x | CN¥63.70 Million | CN¥13.67 Million | CN¥54.83 Million | — |